Virtual Preclinical Specialty Research Department
Basel, Switzerland & Rye, New York, NY (PRWEB) September 25, 2008
Georg J. Krinke, Prof. MVDr, C.Sc, FVH Path., Diplomat E.C.V.P
Dr. Krinke is an independent consultant in experimental and toxicologic pathology, located in Frenkendorf, Switzerland. He is A Professor of veterinary pathology and a world renowned experimental neuropathologist. His numerous engagements include contracts of cooperation with Swiss Agency for Therapeutic products and Swiss Federal Office of Metrology. Dr. Krinke has authored or contributed to over 60 publications in journals, 34 book chapters and numerous published abstracts.
The topics reflect his expertise in pathology, toxicology, histochemistry, and neurotoxicology. He is a member in good standing of numerous professional societies including, the European Society of Toxicologic Pathology, Swiss Society of Veterinary Pathology, British Society of Toxicologic Pathology and the US Society of Toxicologic Pathologists. His professional experience includes significant roles in drug development as well as in development of chemical products with several major Swiss based pharmaceutical companies.
Colin G. Rousseaux, BVSc, PhD, DABT, FRCPath, FIATP, ATS
Dr. Rousseaux is principal of Colin Rousseaux and Associates a diagnostic and research pathology consulting firm with offices in Quebec and Ottawa, Canada. He is also an Adjunct Professor, Department of Pathology and Laboratory Medicine, University of Ottawa; Professeur Associé, Département de Biologie, Université de Québec à Montréal and Adjunct Professor, Faculty of Medicine, University of Alberta, Edmonton. Dr. Rousseaux has authored over 85 scientific publications as well as more than 85 abstracts, including co-editor of "Handbook of Toxicologic Pathology", a standard reference text for pathologists in industrial settings.
"We are thrilled to have Georg and Colin join our Board of Scientific Advisors. Our BSA consists of some the world's leading toxicologic pathologists and toxicologists with extensive backgrounds in device and drug development research. Pathology Experts' BSA is unique in that it can be called upon for opinions regarding active projects. Projects span dug and device research from the preclinical development phase through in-market studies, on an on-demand basis. We believe that our association with this esteemed group of globally recognized top-level scientists and translational researchers support our efforts to deliver the best in class services to our sponsors," said Dr. Maurice Cary, founder and CEO.
Our Mission - Provide the best Independent Toxicologic Pathology Expertise, globally. PELLC enables our clients to augment their product development capability with a "Virtual Preclinical Specialty Research Department".
For further details on services and additional information, please visit our website http://www.pathexperts.com.
The Pathology Experts LLC logo ® is a registered service mark.
Pathology Experts LLC @ 2008 "all rights reserved"